<img src="https://trc.taboola.com/1321591/log/3/unip?en=page_view" width="0" height="0" style="display:none">
Fact Check Library

Fact Check with Logically.

Download the Free App Today

Misleading
misleading

CLAIM ID

104974a3

Joe Biden has reversed President Trump's executive order to reduce the price of epinephrine and insulin.

The Biden administration has implemented a regulatory rule freeze affecting on all rules that had not gone into effect. They will now be reviewed. In his initial acts as the 46th US president, Joe Biden signed several executive orders, some of them reversing former President Donald Trump’s policies. The orders reversed include the Trump administration's policies on climate change, immigration, and COVID-19 response. The Biden administration implemented a regulatory rule freeze affecting all federal agency rules that had not gone into effect as of January 20, 2021. According to National Law Review, "At its core, the regulatory rule freeze requires all pending final rules to be delayed at least 60 days in order for the Biden administration to review and opine on the necessity and scope of affected rules. During this delay period, the administration may review, revise, and possibly rescind federal administrative rules". Modern Healthcare reported that, under this rule, the Department of Health and Human Services (HHS) has frozen "a final rule that would have blocked community health centers, which are federally qualified health centers, from receiving future grant funding unless the centers provided a complete pass-through of 340B discounts on insulin and epi-pens to low-income patients under the 340B Insulin Pass-Through Rule." Community health centers opposed the 340B Insulin Pass-Through Rule, arguing that it would have added significant bureaucratic obligations to centers’ operations while making a relatively minimal impact on the costs of drugs provided to center patients. The 340B Insulin Pass-Through Rule was meant to go into effect on January 22, 2021. Due to HHS’ freeze, the 340B Insulin Pass-Through Rule's effective date has now been pushed to at least March 22, 2021. Moreover, there is currently no indication whether the Biden administration will ultimately repeal or amend the 340B Insulin Pass-Through Rule. This delay also offers community health centers additional time to develop plans to comply with the 340B Insulin Pass-Through Rule.

The Biden administration has implemented a regulatory rule freeze affecting on all rules that had not gone into effect. They will now be reviewed. In his initial acts as the 46th US president, Joe Biden signed several executive orders, some of them reversing former President Donald Trump’s policies. The orders reversed include the Trump administration's policies on climate change, immigration, and COVID-19 response.

The Biden administration implemented a regulatory rule freeze affecting all federal agency rules that had not gone into effect as of January 20, 2021. According to National Law Review, "At its core, the regulatory rule freeze requires all pending final rules to be delayed at least 60 days in order for the Biden administration to review and opine on the necessity and scope of affected rules. During this delay period, the administration may review, revise, and possibly rescind federal administrative rules".

Modern Healthcare reported that, under this rule, the Department of Health and Human Services (HHS) has frozen "a final rule that would have blocked community health centers, which are federally qualified health centers, from receiving future grant funding unless the centers provided a complete pass-through of 340B discounts on insulin and epi-pens to low-income patients under the 340B Insulin Pass-Through Rule." Community health centers opposed the 340B Insulin Pass-Through Rule, arguing that it would have added significant bureaucratic obligations to centers’ operations while making a relatively minimal impact on the costs of drugs provided to center patients. The 340B Insulin Pass-Through Rule was meant to go into effect on January 22, 2021.

Due to HHS’ freeze, the 340B Insulin Pass-Through Rule's effective date has now been pushed to at least March 22, 2021. Moreover, there is currently no indication whether the Biden administration will ultimately repeal or amend the 340B Insulin Pass-Through Rule. This delay also offers community health centers additional time to develop plans to comply with the 340B Insulin Pass-Through Rule.

Have a question or correction?

Please tell us if you think this claim had been misjudged or requires correction by sending us evidence to support your error claim. We will revisit our evidence and verdict and do some additional research to double check if we can verify the new information

Fact Check of the Day

false

The Arizona election audit found tens of thousands of illegitimate ballots.